Chemosynthetic Polypeptide Drugs Market Report

China Chemosynthetic Polypeptide Drugs Industry Market Research Report 2023-2029

  • POSTDATE：Sep 29, 2023
  • PAGES：202
  • REPORT CODE：GMM1818885
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Chemosynthetic polypeptide drugs are composed of certain amino acids that combine to form a single unit. These drugs do produce a considerable remedial effect on different diseases, however, accompanied by a few side effects. Chemosynthetic polypeptide drugs are considered closely important mainly because of the therapeutic and curative effects it offers. Their prime areas of application are curing of diseases like tumor, metabolism, immunoregulation, cardiovascular diseases, and various other infectious diseases. These chemosynthetic polypeptide drugs are much more influential as compared to the traditional drugs, hence will likely replace the existing pharmaceutical drugs. Currently, there are more than 140 polypeptide drugs available in the global market. Some of the major chemosynthetic polypeptide drugs available in the global market are thymalfasin, thymopentin, somatostatin, octreotide and thyrocalcitonin.

    This report elaborates on the current development of the Chemosynthetic Polypeptide Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Amylin Pharmaceuticals

    • Peptides International

    • X-Gen Pharmaceuticals

    • Biovectra

    • Amgen

    • Eli Lilly

    • Novo-Nordisk

    By Type:

    • Icatibant

    • Bacitracin

    • Colistin (Polymyxin E) And Polymyxin B

    • Vasopressin

    • Colistin Methane Sulfonate

    By Application:

    • Drug Stores

    • Retail Pharmacies

    • Hospital Pharmacies

    • Online Sales

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Chemosynthetic Polypeptide Drugs Market Overview 2018-2029

    • 1.1 China Chemosynthetic Polypeptide Drugs Industry Development Overview

    • 1.2 China Chemosynthetic Polypeptide Drugs Industry Development History

    • 1.3 China Chemosynthetic Polypeptide Drugs Industry Market Size (2018-2029)

    • 1.4 China Chemosynthetic Polypeptide Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Chemosynthetic Polypeptide Drugs Production Volume, Production Value and Growth Rate of Icatibant (2018-2029)

      • 1.4.2 China Chemosynthetic Polypeptide Drugs Production Volume, Production Value and Growth Rate of Bacitracin (2018-2029)

      • 1.4.3 China Chemosynthetic Polypeptide Drugs Production Volume, Production Value and Growth Rate of Colistin (Polymyxin E) And Polymyxin B (2018-2029)

      • 1.4.4 China Chemosynthetic Polypeptide Drugs Production Volume, Production Value and Growth Rate of Vasopressin (2018-2029)

      • 1.4.5 China Chemosynthetic Polypeptide Drugs Production Volume, Production Value and Growth Rate of Colistin Methane Sulfonate (2018-2029)

    • 1.5 China Chemosynthetic Polypeptide Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Chemosynthetic Polypeptide Drugs Sales Volume, Sales Value and Growth Rate of Drug Stores (2018-2029)

      • 1.5.2 China Chemosynthetic Polypeptide Drugs Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)

      • 1.5.3 China Chemosynthetic Polypeptide Drugs Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)

      • 1.5.4 China Chemosynthetic Polypeptide Drugs Sales Volume, Sales Value and Growth Rate of Online Sales (2018-2029)

    • 1.6 China Chemosynthetic Polypeptide Drugs Market Analysis by Region

      • 1.6.1 North China Chemosynthetic Polypeptide Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Chemosynthetic Polypeptide Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Chemosynthetic Polypeptide Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Chemosynthetic Polypeptide Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Chemosynthetic Polypeptide Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Chemosynthetic Polypeptide Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Chemosynthetic Polypeptide Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Chemosynthetic Polypeptide Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Chemosynthetic Polypeptide Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Chemosynthetic Polypeptide Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Chemosynthetic Polypeptide Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Chemosynthetic Polypeptide Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Chemosynthetic Polypeptide Drugs Industry Development

    Chapter 3 Chemosynthetic Polypeptide DrugsIndustry Chain Analysis

    • 3.1 Chemosynthetic Polypeptide Drugs Industry Chain

    • 3.2 Chemosynthetic Polypeptide Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Chemosynthetic Polypeptide Drugs Market

    • 3.3 Chemosynthetic Polypeptide Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Chemosynthetic Polypeptide Drugs Market

    Chapter 4 China Chemosynthetic Polypeptide Drugs Market, by Type

    • 4.1 China Chemosynthetic Polypeptide Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Chemosynthetic Polypeptide Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Chemosynthetic Polypeptide Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Chemosynthetic Polypeptide Drugs Production Volume and Growth Rate of Icatibant

      • 4.5.2 China Chemosynthetic Polypeptide Drugs Production Volume and Growth Rate of Bacitracin

      • 4.5.3 China Chemosynthetic Polypeptide Drugs Production Volume and Growth Rate of Colistin (Polymyxin E) And Polymyxin B

      • 4.5.4 China Chemosynthetic Polypeptide Drugs Production Volume and Growth Rate of Vasopressin

      • 4.5.5 China Chemosynthetic Polypeptide Drugs Production Volume and Growth Rate of Colistin Methane Sulfonate

    Chapter 5 China Chemosynthetic Polypeptide Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Chemosynthetic Polypeptide Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Chemosynthetic Polypeptide Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Chemosynthetic Polypeptide Drugs Market Size and Growth Rate of Drug Stores

      • 5.5.2 China Chemosynthetic Polypeptide Drugs Market Size and Growth Rate of Retail Pharmacies

      • 5.5.3 China Chemosynthetic Polypeptide Drugs Market Size and Growth Rate of Hospital Pharmacies

      • 5.5.4 China Chemosynthetic Polypeptide Drugs Market Size and Growth Rate of Online Sales

    Chapter 6 China Chemosynthetic Polypeptide Drugs Market, by Region

    • 6.1 China Chemosynthetic Polypeptide Drugs Production Volume and Production Value, by Region

    • 6.2 China Chemosynthetic Polypeptide Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Chemosynthetic Polypeptide Drugs Market Analysis

    • 7.1 North China Chemosynthetic Polypeptide Drugs Market, by Type

    • 7.2 North China Chemosynthetic Polypeptide Drugs Market, by Application

    Chapter 8 Central China Chemosynthetic Polypeptide Drugs Market Analysis

    • 8.1 Central China Chemosynthetic Polypeptide Drugs Market, by Type

    • 8.2 Central China Chemosynthetic Polypeptide Drugs Market, by Application

    Chapter 9 South China Chemosynthetic Polypeptide Drugs Market Analysis

    • 9.1 South China Chemosynthetic Polypeptide Drugs Market, by Type

    • 9.2 South China Chemosynthetic Polypeptide Drugs Market, by Application

    Chapter 10 East China Chemosynthetic Polypeptide Drugs Market Analysis

    • 10.1 East China Chemosynthetic Polypeptide Drugs Market, by Type

    • 10.2 East China Chemosynthetic Polypeptide Drugs Market, by Application

    Chapter 11 Northeast China Chemosynthetic Polypeptide Drugs Market Analysis

    • 11.1 Northeast China Chemosynthetic Polypeptide Drugs Market, by Type

    • 11.2 Northeast China Chemosynthetic Polypeptide Drugs Market, by Application

    Chapter 12 Southwest China Chemosynthetic Polypeptide Drugs Market Analysis

    • 12.1 Southwest China Chemosynthetic Polypeptide Drugs Market, by Type

    • 12.2 Southwest China Chemosynthetic Polypeptide Drugs Market, by Application

    Chapter 13 Northwest China Chemosynthetic Polypeptide Drugs Market Analysis

    • 13.1 Northwest China Chemosynthetic Polypeptide Drugs Market, by Type

    • 13.2 Northwest China Chemosynthetic Polypeptide Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Amylin Pharmaceuticals

        • 14.1.1 Amylin Pharmaceuticals Company Profile

        • 14.1.2 Amylin Pharmaceuticals Chemosynthetic Polypeptide Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Peptides International

        • 14.2.1 Peptides International Company Profile

        • 14.2.2 Peptides International Chemosynthetic Polypeptide Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 X-Gen Pharmaceuticals

        • 14.3.1 X-Gen Pharmaceuticals Company Profile

        • 14.3.2 X-Gen Pharmaceuticals Chemosynthetic Polypeptide Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Biovectra

        • 14.4.1 Biovectra Company Profile

        • 14.4.2 Biovectra Chemosynthetic Polypeptide Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Amgen

        • 14.5.1 Amgen Company Profile

        • 14.5.2 Amgen Chemosynthetic Polypeptide Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Eli Lilly

        • 14.6.1 Eli Lilly Company Profile

        • 14.6.2 Eli Lilly Chemosynthetic Polypeptide Drugs Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Novo-Nordisk

        • 14.7.1 Novo-Nordisk Company Profile

        • 14.7.2 Novo-Nordisk Chemosynthetic Polypeptide Drugs Market Performance

        • 14.7.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Chemosynthetic Polypeptide Drugs Industry Research Conclusions

    • 15.2 Chemosynthetic Polypeptide Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Chemosynthetic Polypeptide Drugs Industry Market Size (2018-2029)

    • Figure China Chemosynthetic Polypeptide Drugs Production Volume, Production Value and Growth Rate of Icatibant (2018-2029)

    • Figure China Chemosynthetic Polypeptide Drugs Production Volume, Production Value and Growth Rate of Bacitracin (2018-2029)

    • Figure China Chemosynthetic Polypeptide Drugs Production Volume, Production Value and Growth Rate of Colistin (Polymyxin E) And Polymyxin B (2018-2029)

    • Figure China Chemosynthetic Polypeptide Drugs Production Volume, Production Value and Growth Rate of Vasopressin (2018-2029)

    • Figure China Chemosynthetic Polypeptide Drugs Production Volume, Production Value and Growth Rate of Colistin Methane Sulfonate (2018-2029)

    • Figure China Chemosynthetic Polypeptide Drugs Sales Volume, Sales Value and Growth Rate of Drug Stores (2018-2029)

    • Figure China Chemosynthetic Polypeptide Drugs Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)

    • Figure China Chemosynthetic Polypeptide Drugs Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)

    • Figure China Chemosynthetic Polypeptide Drugs Sales Volume, Sales Value and Growth Rate of Online Sales (2018-2029)

    • Figure North China Chemosynthetic Polypeptide Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Chemosynthetic Polypeptide Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Chemosynthetic Polypeptide Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Chemosynthetic Polypeptide Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Chemosynthetic Polypeptide Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Chemosynthetic Polypeptide Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Chemosynthetic Polypeptide Drugs Market Size and Growth Rate from 2018-2029

    • Figure Chemosynthetic Polypeptide Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Chemosynthetic Polypeptide Drugs Market Share by Type in 2018

    • Figure China Chemosynthetic Polypeptide Drugs Market Share by Type in 2023

    • Figure China Chemosynthetic Polypeptide Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Chemosynthetic Polypeptide Drugs Production Volume and Growth Rate of Icatibant (2018-2023)

    • Figure China Chemosynthetic Polypeptide Drugs Production Volume and Growth Rate of Bacitracin (2018-2023)

    • Figure China Chemosynthetic Polypeptide Drugs Production Volume and Growth Rate of Colistin (Polymyxin E) And Polymyxin B (2018-2023)

    • Figure China Chemosynthetic Polypeptide Drugs Production Volume and Growth Rate of Vasopressin (2018-2023)

    • Figure China Chemosynthetic Polypeptide Drugs Production Volume and Growth Rate of Colistin Methane Sulfonate (2018-2023)

    • Figure China Chemosynthetic Polypeptide Drugs Market Share by Application in 2018

    • Figure China Chemosynthetic Polypeptide Drugs Market Share by Application in 2023

    • Figure China Chemosynthetic Polypeptide Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Chemosynthetic Polypeptide Drugs Market Size and Growth Rate of Drug Stores (2018-2023)

    • Figure China Chemosynthetic Polypeptide Drugs Market Size and Growth Rate of Retail Pharmacies (2018-2023)

    • Figure China Chemosynthetic Polypeptide Drugs Market Size and Growth Rate of Hospital Pharmacies (2018-2023)

    • Figure China Chemosynthetic Polypeptide Drugs Market Size and Growth Rate of Online Sales (2018-2023)

    • Table China Chemosynthetic Polypeptide Drugs Production Volume by Region (2018-2023)

    • Table China Chemosynthetic Polypeptide Drugs Production Volume Share by Region (2018-2023)

    • Figure China Chemosynthetic Polypeptide Drugs Production Volume Share by Region (2018-2023)

    • Table China Chemosynthetic Polypeptide Drugs Production Value by Region (2018-2023)

    • Table China Chemosynthetic Polypeptide Drugs Production Value Share by Region (2018-2023)

    • Figure China Chemosynthetic Polypeptide Drugs Production Value Share by Region (2018-2023)

    • Table China Chemosynthetic Polypeptide Drugs Sales Volume by Region (2018-2023)

    • Table China Chemosynthetic Polypeptide Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Chemosynthetic Polypeptide Drugs Sales Volume Share by Region (2018-2023)

    • Table China Chemosynthetic Polypeptide Drugs Sales Value by Region (2018-2023)

    • Table China Chemosynthetic Polypeptide Drugs Sales Value Share by Region (2018-2023)

    • Figure China Chemosynthetic Polypeptide Drugs Sales Value Share by Region (2018-2023)

    • Table North China Chemosynthetic Polypeptide Drugs Production Volume by Type (2018-2023)

    • Table North China Chemosynthetic Polypeptide Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Chemosynthetic Polypeptide Drugs Production Volume Share by Type (2018-2023)

    • Table North China Chemosynthetic Polypeptide Drugs Sales Volume by Application (2018-2023)

    • Table North China Chemosynthetic Polypeptide Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Chemosynthetic Polypeptide Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Chemosynthetic Polypeptide Drugs Production Volume by Type (2018-2023)

    • Table Central China Chemosynthetic Polypeptide Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Chemosynthetic Polypeptide Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Chemosynthetic Polypeptide Drugs Sales Volume by Application (2018-2023)

    • Table Central China Chemosynthetic Polypeptide Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Chemosynthetic Polypeptide Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Chemosynthetic Polypeptide Drugs Production Volume by Type (2018-2023)

    • Table South China Chemosynthetic Polypeptide Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Chemosynthetic Polypeptide Drugs Production Volume Share by Type (2018-2023)

    • Table South China Chemosynthetic Polypeptide Drugs Sales Volume by Application (2018-2023)

    • Table South China Chemosynthetic Polypeptide Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Chemosynthetic Polypeptide Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Chemosynthetic Polypeptide Drugs Production Volume by Type (2018-2023)

    • Table East China Chemosynthetic Polypeptide Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Chemosynthetic Polypeptide Drugs Production Volume Share by Type (2018-2023)

    • Table East China Chemosynthetic Polypeptide Drugs Sales Volume by Application (2018-2023)

    • Table East China Chemosynthetic Polypeptide Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Chemosynthetic Polypeptide Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Chemosynthetic Polypeptide Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Chemosynthetic Polypeptide Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Chemosynthetic Polypeptide Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Chemosynthetic Polypeptide Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Chemosynthetic Polypeptide Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Chemosynthetic Polypeptide Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Chemosynthetic Polypeptide Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Chemosynthetic Polypeptide Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Chemosynthetic Polypeptide Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Chemosynthetic Polypeptide Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Chemosynthetic Polypeptide Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Chemosynthetic Polypeptide Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Chemosynthetic Polypeptide Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Chemosynthetic Polypeptide Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Chemosynthetic Polypeptide Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Chemosynthetic Polypeptide Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Chemosynthetic Polypeptide Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Chemosynthetic Polypeptide Drugs Sales Volume Share by Application (2018-2023)

    • Table Amylin Pharmaceuticals Company Profile

    • Table Amylin Pharmaceuticals Chemosynthetic Polypeptide Drugs Revenue, Price and Gross (2018-2023)

    • Table Peptides International Company Profile

    • Table Peptides International Chemosynthetic Polypeptide Drugs Revenue, Price and Gross (2018-2023)

    • Table X-Gen Pharmaceuticals Company Profile

    • Table X-Gen Pharmaceuticals Chemosynthetic Polypeptide Drugs Revenue, Price and Gross (2018-2023)

    • Table Biovectra Company Profile

    • Table Biovectra Chemosynthetic Polypeptide Drugs Revenue, Price and Gross (2018-2023)

    • Table Amgen Company Profile

    • Table Amgen Chemosynthetic Polypeptide Drugs Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly Company Profile

    • Table Eli Lilly Chemosynthetic Polypeptide Drugs Revenue, Price and Gross (2018-2023)

    • Table Novo-Nordisk Company Profile

    • Table Novo-Nordisk Chemosynthetic Polypeptide Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US